Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
CRISPR/Cas9-Based Screening of FDA-Approved Drugs for NRF2 Activation: A Novel Approach to Discover Therapeutics for Non-Alcoholic Fatty Liver Disease.
Antioxidants (Basel). 2023 Jun 29;12(7):1363. doi: 10.3390/antiox12071363.
Antioxidants (Basel). 2023.
PMID: 37507903
Free PMC article.
Identification of Inhibitors of Tubulin Polymerization Using a CRISPR-Edited Cell Line with Endogenous Fluorescent Tagging of β-Tubulin and Histone H1.
Khachatryan H, Olszowy B, Barrero CA, Gordon J, Perez-Leal O.
Khachatryan H, et al. Among authors: olszowy b.
Biomolecules. 2023 Jan 29;13(2):249. doi: 10.3390/biom13020249.
Biomolecules. 2023.
PMID: 36830618
Free PMC article.
Item in Clipboard
Cite
Cite